Update on GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract


Authors: Weller, M.; Berry, D. A.; Blondin, N.; Buxton, M.; Colman, H.; de Groot, J. F.; de la Fuente, M.; Ducray, F.; Ellingson, B.; Gordon, G.; Lassman, A. B.; Lee, E.; Lim, M.; Mellinghoff, I.; Perry, J.; Sulman, E.; Yung, W. K. A.; Wen, P.; Wick, A.; Cloughesy, T.
Abstract Title: Update on GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sept 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S426
End Page: S427
Language: English
ACCESSION: WOS:001326612900494
DOI: 10.1016/j.annonc.2024.08.569
PROVIDER: wos
Notes: Meeting Abstract: 500TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors